3Navarria I, Usel M, Rapiti E, et al. Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment [ J ]. Gynecol Onco1,2009,114 ( 3 ) :448 - 451.
5Yang S, Thiel KW, Leslie KK. Progesterone : the ultimate endometri- al tumor suppressor[ J ]. Trends Endocrinol Metabol, 2011,22 (4) : 145 - 152.
6Laurelli G, Di Vagno G, Scaffa C, et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study[ J]. Gy- necol Oncol, 2011,120 ( 1 ) :43 - 46.
7Cade T, Quinn M, Rome R, et al. Progestogen treatment options for early endometrial cancer [ J ]. B JOG,2010,117 ( 7 ) :879 - 884.
3Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin ,2010,60:277-300.
4Mariani A, Webb M J, Keeney GL, et al. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol,2001,81 : 100-104.
5Karasek K, Faul C. Changing concepts in the management of endometrial cancer. Oncology ( Williston Park), 1996,10: 1099- 1106.
6Yokoyama Y, Maruyama H, Sato S, et al. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol, 1997,64:411-417.
7Chi DS, Barakat RR, Palayekar MJ, et al. The incidence ofpelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer,2008,18:269-273.
8Kamura T, Yahata H, Shigematsu T, et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol, 1999,72:387-391.
9Fotiou S, Trimble EL, Papakonstantinou K, et al. Complete pelvic lymphadenectomy in patients with clinical early, grade I and Ⅱ endometrioid corpus cancer. Anticancer Res, 2009,29 : 2781-2785.
10Lee KB, Ki KD, Lee JM, et al. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine eaneers:a multicenter, retrospective Korean study. Ann Surg 0ncol,2009,16:2882-2887.
5Marret H, Fauconnier A, Chabbert — Buffet N,et al. Clinicalpractice guidelines on menorrhagia : management of abnormaluterine bleeding before menopause [j ]. Eur J Obstet GynecolReprod Biol, 2010,152(2): 133.
6Lacey JV Jr, Ioffe 〇 B, Ronnett B M,et al. Endometrialnyperplasia: the 34 一 year experience in a large health plan[J]. Br J Cancer, 2008,98(1): 45.
7Cao K, Gao M, Sun YS, et al. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness [ J ]. Eur J Radiol, 2012,81 ( 8 ) : 1926-30. doi : 10. 1016/j. ejrad. 2011.04. 019.
8Giuseppe Laurelli, Giovanni Di Vagno, Cono Scaffa, et al. Conservative treatment of early endometrial cancer: Preliminary resultS of a pilot study [ J ]. Gynecol Oncol, 2011,120 ( 1 ) : 43-46.
9Sweet MG, Schmidt-Dalton TA, Weiss PM, et al. Evaluation and management of abnormal uterine bleeding in premenopausal women[J]. Am Fam Physieian,2012,85(l) :35-43.
10Kleebkaow P, Maneetab S, Somboonporn W, et al. Preoperative and postoperative agreement of histopathological findings in cases of endometrial hyperplasia[J]. Asian Pac J Cancer Prey, 2008,9(1) :89-91.
